Developing blood tests to improve cancer screening accuracy
Biomarker Developmental Laboratory
This study is working on new blood tests to help find lung and ovarian cancers more accurately, so patients can get better screenings and earlier treatment without worrying about false alarms from CT scans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10927277 on NIH RePORTER |
What this research studies
This research focuses on creating new blood tests that can help detect lung and ovarian cancers more accurately. By analyzing specific antibodies in the blood, the study aims to reduce the number of false positives from CT scans and improve the effectiveness of ovarian cancer screenings when combined with existing tests. The approach involves examining immune responses to various antigens to differentiate between cancerous and non-cancerous conditions. Patients may benefit from more reliable screening methods that could lead to earlier detection and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for lung or ovarian cancer, particularly those undergoing screening procedures.
Not a fit: Patients with cancers other than lung or ovarian cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer screenings, reducing unnecessary surgeries and improving early detection rates.
How similar studies have performed: Previous research has shown promising results in using autoantibody biomarkers for cancer detection, indicating a potential for success in this approach.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Anderson, Karen Sue — Arizona State University-Tempe Campus
- Study coordinator: Anderson, Karen Sue
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.